Ivicentamab
Ivicentamab (GEN-3009) is an IgG1κ-type bispecific antibody targeting different epitopes of CD37. Ivicentamab can be used for cancer research[1].
Product Specifications
CAS Number
2364496-42-2
Product Name Alternative
GEN-3009
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ivicentamab.html
Purity
99.82
Solubility
10 mM in DMSO
Smiles
[Ivicentamab]
Molecular Weight
(144.88 kDa)
References & Citations
[1]Balocco Mattavelli. International Nonproprietary Names Programme and Classification of Medical Products. World Health Organization International Nonproprietary Names.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2705207 1.0 µg DNA
ZNF423 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
bs-9639R-BF594-TR 20 µL
C17orf42 Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details K1886007 1.0 µg DNA
RPL7AP47 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details LV654153 1.0 µg DNA
FAM209A Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details